The latest closing stock price for Oramed Pharmaceuticals as of January 17, 2025 is 2.28.
An investor who bought $1,000 worth of Oramed Pharmaceuticals stock at the IPO in 2007 would have $-712 today, roughly -1 times their original investment - a -6.68% compound annual growth rate over 18 years.
The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
The Oramed Pharmaceuticals 52-week high stock price is 3.67, which is 61% above the current share price.
The Oramed Pharmaceuticals 52-week low stock price is 2.00, which is 12.3% below the current share price.
The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.50.
An investor who bought $1,000 worth of Oramed Pharmaceuticals stock at the IPO in 2007 would have $-712 today, roughly -1 times their original investment - a -6.68% compound annual growth rate over 18 years.
The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
The Oramed Pharmaceuticals 52-week high stock price is 3.67, which is 61% above the current share price.
The Oramed Pharmaceuticals 52-week low stock price is 2.00, which is 12.3% below the current share price.
The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.50.